• Cell lysis buffer for WB and IP: Optimizing Tumor Microenvir

  2026-05-31

  Unlock precise and reproducible protein extraction for Western blot and immunoprecipitation with APExBIO's Cell lysis buffer for WB and IP. This non-denaturing buffer preserves native protein complexes and signaling, empowering advanced tumor microenvironment research and mechanistic studies on chemoresistance.

• Lypressin Acetate: Benchmarks in Vasopressin Analog Research

  2026-05-30

  Lypressin acetate is a natural peptide analog of vasopressin, widely used as an antidiuretic and vasopressor agent. Its well-characterized biological activities and stability profile make it a benchmark tool in diabetes insipidus treatment and vasoconstriction research. This article reviews evidence, protocols, and clarifies misconceptions relevant to biomedical research and translational workflows.

• Allosteric PDK4 Inhibitors for Metabolic and Allergic Diseas

  2026-05-29

  Jeon et al. present a new class of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, notably compound 8c, which demonstrates nanomolar potency and in vivo efficacy in metabolic and allergic disease models. These findings highlight PDK4’s central role in metabolic regulation and inflammation, offering promising avenues for therapeutic modulation supported by robust chemical and pharmacological profiling.

• 3X (DYKDDDDK) Peptide: Optimizing Flag Tag Protein Workflows

  2026-05-29

  The 3X (DYKDDDDK) Peptide elevates recombinant protein detection, affinity purification, and structural studies with its hydrophilic, triple-epitope design. Explore protocol enhancements, troubleshooting tips, and the unique advantages of this APExBIO reagent in cutting-edge molecular biology workflows.

• Stattic: Potent STAT3 Inhibitor for HNSCC & Cancer Biology

  2026-05-28

  Stattic is a selective STAT3 inhibitor that disrupts STAT3 dimerization and nuclear translocation, leading to reduced tumor growth and enhanced radiosensitivity in head and neck squamous cell carcinoma (HNSCC) models. Its efficacy and specificity make it a key tool for apoptosis induction studies in cancer biology.

• ApoE-Mimetic Peptide COG133 Modulates miR-146a in Diabetic W

  2026-05-28

  The referenced study investigates the therapeutic potential of the ApoE-mimetic peptide COG133 in diabetic dermal fibroblasts, focusing on the regulation of miR-146a and its impact on inflammation and antibacterial activity. This work highlights a novel approach to addressing impaired wound healing in diabetes by targeting miRNA-mediated inflammatory pathways.

• Naloxone Hydrochloride: Beyond Antagonism in Stem Cell and I

  2026-05-27

  Explore how Naloxone hydrochloride, a leading opioid receptor antagonist, advances neural stem cell research and immune modulation. This article uncovers unique receptor-dependent and independent mechanisms, offering new perspectives for innovative assay design.

• Substance P: Applied Workflows for Pain and Inflammation Res

  2026-05-27

  Substance P, a benchmark tachykinin neuropeptide, enables advanced modeling of pain transmission, neuroinflammation, and immune response modulation. This guide delivers actionable workflow enhancements, spectral analytics integration, and troubleshooting strategies to maximize research outcomes using APExBIO’s high-purity Substance P.

• Sulfo-NHS-SS-Biotin: Advanced Protein Labeling for Affinity

  2026-05-26

  Sulfo-NHS-SS-Biotin is redefining reversible protein labeling and affinity purification, offering water solubility and a cleavable disulfide bond for precision workflows. Explore how this biotin disulfide N-hydroxysulfosuccinimide ester empowers dynamic proteostasis research and surface-exposed protein analysis with unprecedented flexibility.

• 25-Hydroxycholesterol Drives Immunosuppressive TAM Metabolis

  2026-05-26

  Xiao et al. reveal that 25-hydroxycholesterol (25HC) accumulation in tumor-associated macrophages (TAMs) drives immunosuppression by activating lysosomal AMPKα and inducing a metabolic shift that sustains STAT6-ARG1 signaling. This mechanistic insight informs immunometabolic intervention strategies and highlights CH25H as a checkpoint for anti-tumor immunity.

• KX2-391 Dihydrochloride: Dual-Action Assays in Oncology and

  2026-05-25

  KX2-391 dihydrochloride (Tirbanibulin dihydrochloride) stands apart as a dual mechanism Src kinase and tubulin polymerization inhibitor with validated activity in cancer, viral, and neurotoxin research. This guide delivers applied protocols, optimization strategies, and troubleshooting tips to maximize reproducibility and data quality across these domains.

• Eliminating Pollen Interference in Fluorescence Bioaerosol D

  2026-05-25

  The reference study demonstrates a machine learning-driven strategy to overcome pollen spectral interference during hazardous bioaerosol classification using excitation–emission matrix fluorescence spectroscopy. This work substantially improves the accuracy of detecting pathogenic bacteria and toxins in complex airborne mixtures, providing a methodological advance for environmental and public health monitoring.

• Evaluating Fumagillin for Control of Azumiobodo hoyamushi in

  2026-05-24

  This study systematically investigated twenty antiprotozoal agents—including Fumagillin—for their efficacy against Azumiobodo hoyamushi, the causative agent of soft tunic syndrome in edible ascidians. The findings provide evidence-based guidance for selecting candidate drugs in aquaculture disease management and highlight the translational relevance of methionine aminopeptidase-2 inhibitors.

• Cell lysis buffer for WB and IP: Powering Robust Protein Ext

  2026-05-23

  Unlock high-yield, non-denaturing protein extraction from challenging samples—animal, plant, or microbial—with Cell lysis buffer for WB and IP. Learn how optimized inhibitor cocktails and workflow tuning boost Western blot and immunoprecipitation sensitivity, especially in complex tumor microenvironment studies.

• PF-562271 HCl: Advanced FAK/Pyk2 Inhibitor Workflows in Canc

  2026-05-22

  PF-562271 HCl empowers researchers to dissect focal adhesion kinase signaling with precise, selective inhibition, offering robust tools for modeling tumor growth and metastasis. This guide translates bench-proven workflows and troubleshooting strategies into actionable, reproducible cancer research protocols.

14865 records 1/991 page Next 12345 下5页 Last page